15/06/2022 - 16:40

Radiopharm locks in supply deal for cancer therapy

15/06/2022 - 16:40

Bookmark

Save articles for future reference.

Cancer fighter Radiopharm Theranostics has inked a deal for the supply of a key component needed to develop its pipeline of radiopharmaceutical therapy products. Radiopharm says its agreement with Israeli company Isotopia Molecular Imaging for a high-quality radioisotope called Lutetium-177 will enable it to accelerate its diverse clinical pipeline of radiopharmaceutical products slated for the multi-billion-dollar oncology market.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options